Cargando…
mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential
Metastasis is the biggest challenge in treating breast cancer, and it kills >40,000 breast cancer patients annually in the US. Aberrant expression of the RON receptor tyrosine kinase in breast tumors correlates with poor prognosis and has been shown to promote metastasis. However, the molecular m...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226524/ https://www.ncbi.nlm.nih.gov/pubmed/30456298 http://dx.doi.org/10.1038/s41523-018-0091-5 |